The Role of Granulocyte Transfusions in Optimizing Candidacy for Chimeric Antigen Receptor T-cell Therapy in Patients With Treatment-refractory Infections.
Publication
, Journal Article
Tambaro, FP; Ragoonanan, D; Tewari, P; Petropoulos, D; Aung, FM; Mahadeo, KM; Khazal, S
Published in: J Pediatr Hematol Oncol
March 1, 2022
While advancements in cellular therapy have improved outcomes for patients with refractory leukemia, severe infections may hinder access. Granulocyte transfusions, in combination with anti-microbial therapy, may be a safe option to facilitate candidacy for chimeric antigen receptor T-cell therapy in patients with leukemia and prolonged immune-compromised status.
Duke Scholars
Published In
J Pediatr Hematol Oncol
DOI
EISSN
1536-3678
Publication Date
March 1, 2022
Volume
44
Issue
2
Start / End Page
e463 / e466
Location
United States
Related Subject Headings
- Receptors, Chimeric Antigen
- Receptors, Antigen, T-Cell
- Oncology & Carcinogenesis
- Leukemia
- Immunotherapy, Adoptive
- Humans
- Granulocytes
- Cell- and Tissue-Based Therapy
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Tambaro, F. P., Ragoonanan, D., Tewari, P., Petropoulos, D., Aung, F. M., Mahadeo, K. M., & Khazal, S. (2022). The Role of Granulocyte Transfusions in Optimizing Candidacy for Chimeric Antigen Receptor T-cell Therapy in Patients With Treatment-refractory Infections. J Pediatr Hematol Oncol, 44(2), e463–e466. https://doi.org/10.1097/MPH.0000000000002111
Tambaro, Francesco P., Dristhi Ragoonanan, Priti Tewari, Demetrios Petropoulos, Fleur M. Aung, Kris M. Mahadeo, and Sajad Khazal. “The Role of Granulocyte Transfusions in Optimizing Candidacy for Chimeric Antigen Receptor T-cell Therapy in Patients With Treatment-refractory Infections.” J Pediatr Hematol Oncol 44, no. 2 (March 1, 2022): e463–66. https://doi.org/10.1097/MPH.0000000000002111.
Tambaro FP, Ragoonanan D, Tewari P, Petropoulos D, Aung FM, Mahadeo KM, et al. The Role of Granulocyte Transfusions in Optimizing Candidacy for Chimeric Antigen Receptor T-cell Therapy in Patients With Treatment-refractory Infections. J Pediatr Hematol Oncol. 2022 Mar 1;44(2):e463–6.
Tambaro, Francesco P., et al. “The Role of Granulocyte Transfusions in Optimizing Candidacy for Chimeric Antigen Receptor T-cell Therapy in Patients With Treatment-refractory Infections.” J Pediatr Hematol Oncol, vol. 44, no. 2, Mar. 2022, pp. e463–66. Pubmed, doi:10.1097/MPH.0000000000002111.
Tambaro FP, Ragoonanan D, Tewari P, Petropoulos D, Aung FM, Mahadeo KM, Khazal S. The Role of Granulocyte Transfusions in Optimizing Candidacy for Chimeric Antigen Receptor T-cell Therapy in Patients With Treatment-refractory Infections. J Pediatr Hematol Oncol. 2022 Mar 1;44(2):e463–e466.
Published In
J Pediatr Hematol Oncol
DOI
EISSN
1536-3678
Publication Date
March 1, 2022
Volume
44
Issue
2
Start / End Page
e463 / e466
Location
United States
Related Subject Headings
- Receptors, Chimeric Antigen
- Receptors, Antigen, T-Cell
- Oncology & Carcinogenesis
- Leukemia
- Immunotherapy, Adoptive
- Humans
- Granulocytes
- Cell- and Tissue-Based Therapy
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology